-
1
-
-
84931868285
-
Línsufissance rénale circulatoire spontané du cirrhotique. Son évolution
-
Vesin P. Traverso H. Hirsch-Marie H. Catan R. Línsufissance rénale circulatoire spontané du cirrhotique. Son évolution Sem Hôp Paris 38 1962 3598 3602
-
(1962)
Sem Hôp Paris
, vol.38
, pp. 3598-3602
-
-
Vesin, P.1
Traverso, H.2
Hirsch-Marie, H.3
Catan, R.4
-
2
-
-
49749165998
-
Electrolyte and circulatory changes in terminal liver failure
-
Hecker R. Sherlock S. Electrolyte and circulatory changes in terminal liver failure Lancet 2 1956 1121 1125
-
(1956)
Lancet
, vol.2
, pp. 1121-1125
-
-
Hecker, R.1
Sherlock, S.2
-
4
-
-
0030052899
-
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
-
Arroyo V. Ginès P. Gerbes A.L. Dudley F.J. Gentilini P. Laffi G. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis Heparology 23 1996 164 176
-
(1996)
Heparology
, vol.23
, pp. 164-176
-
-
Arroyo, V.1
Ginès, P.2
Gerbes, A.L.3
Dudley, F.J.4
Gentilini, P.5
Laffi, G.6
-
5
-
-
0001915835
-
Treatment of hepatorenal syndrome in cirrhosis
-
Arroyo V. Bataller R. Guevara M. Treatment of hepatorenal syndrome in cirrhosis Arroyo V. Ginès P. Rodés J. Schrier R.W. Ascites and Renal Dysfunction in Liver Disease. Pathogenesis, Diagnosis and Treatment 1999 Blackwell Science Malden, MA 492 510
-
(1999)
, pp. 492-510
-
-
Arroyo, V.1
Bataller, R.2
Guevara, M.3
-
7
-
-
0033065188
-
Reversal of type 1 heparorenal syndrome with the administration of midodrine and octeotride
-
Angeli P. Volpin R. Gerunda G. Craighero R. Roner P. Merenda R. Reversal of type 1 heparorenal syndrome with the administration of midodrine and octeotride Hepatology 29 1999 1690 1697
-
(1999)
Hepatology
, vol.29
, pp. 1690-1697
-
-
Angeli, P.1
Volpin, R.2
Gerunda, G.3
Craighero, R.4
Roner, P.5
Merenda, R.6
-
8
-
-
0032885451
-
Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine
-
Gülberg V. Bilzer M. Gerbes A.L. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine Hepatology 30 1999 870 875
-
(1999)
Hepatology
, vol.30
, pp. 870-875
-
-
Gülberg, V.1
Bilzer, M.2
Gerbes, A.L.3
-
9
-
-
85120097217
-
-
Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W., Salmerón J.M. et.al., Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome, Results of a pilot study. J Hepatol (in press).
-
-
-
-
10
-
-
0042429572
-
Transjugular intrahepatic porrosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
-
Guevara M. Ginès P. Bandi J.C. Gilabert R. Sort P. Jiménez W. Transjugular intrahepatic porrosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems Heparology 28 1998 416 422
-
(1998)
Heparology
, vol.28
, pp. 416-422
-
-
Guevara, M.1
Ginès, P.2
Bandi, J.C.3
Gilabert, R.4
Sort, P.5
Jiménez, W.6
-
11
-
-
0033527033
-
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis
-
Sort P. Navasa M. Arroyo V. Aldeguer X. Planas R. Ruiz-delArbol L. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 1999 403 409
-
(1999)
N Engl J Med
, vol.341
, pp. 403-409
-
-
Sort, P.1
Navasa, M.2
Arroyo, V.3
Aldeguer, X.4
Planas, R.5
Ruiz-delArbol, L.6
-
12
-
-
0034109694
-
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, controlled clinical trial
-
Mitzner S.R. Stange J. Klammt S. Risler T. Erley C.M. Bader B.D. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, controlled clinical trial Liver Transpl 6 2000 277 286
-
(2000)
Liver Transpl
, vol.6
, pp. 277-286
-
-
Mitzner, S.R.1
Stange, J.2
Klammt, S.3
Risler, T.4
Erley, C.M.5
Bader, B.D.6
|